![](https://static.igem.org/mediawiki/2017/e/e2/Arrow2PB.png)
RNA Organelle
RNA Aggregation
In synthetic biology, we are often introducing new pathways to bacteria that do not naturally express them. The novel pathway will produce exotic enzymes and proteins which the host bacteria will not necessarily have the internal environment in order to organise these macromolecular products. Ultimately, this could be detrimental to the performance of both the pathway and the organism itself. Additionally, depending on the organism used, the activity of the pathway can vary and be difficult to characterise against other models used. Thus, we aim to standardize the microenvironmental activity of different pathways within the cell by localising the associated enzymes/proteins in an RNA based structure, leading to the pathway to act in a predictable way, regardless of the organism.![](https://static.igem.org/mediawiki/2017/6/65/RNA_wiki_1.png)
In mammalian cells, RNA containing triplet repeats of nucleotides such as CAGCAGCAGCAG have been observed to aggregate in the nucleus. The properties of the RNA aggregation is similar to those seen in liquid-liquid phase separated molecules, which can be visualized as oil droplets in water. The densely compact RNA strands will allow small molecules or substrates to pass through the structure while maintaining a different internal environment. Using this idea, we aimed to express RNA containing repeats in bacterial cells, in order to develop an intracellular scaffold. The scaffold will act as the basis of a synthetic organelle, which could be used in both the standardization of pathway activity in vivo and in cell-free systems as a specialised organelle.
In Vivo Scaffolding
Model Prediction
The modelling of the organelle’s kinetics showed that when the rate of reaction (k) between A and B is low, the non-specific homogenous mixture would have a higher rate of production. Although, if k is at a high rate and more specific binding, the organelle would have an exponentially higher rate of production for the reaction of A and B. The model indicates that the organelle prefers higher constant specific reactions.
![](https://static.igem.org/mediawiki/2017/a/ac/RNA_Modelling.png)
![](https://static.igem.org/mediawiki/2017/6/62/In_vivo_FAFB_System.png)
FA-FB System
The FA-FB system is a visualisation method that uses two components of a split GFP, FA and FB, which can bind together to form a complete GFP. Usually, the two components are linked to specific aptamers which bind to their respective domains, allowing the GFP to be present at the site of interest. The FA component is expressed an MS2 aptamer, which is a specific bacteriophage binding site that connects an MS2 binding domain. By expressing the CAG repeat sequence with an MS2 binding domain (fig. 2A), specific binding can occur on the RNA aggregation. Thus, this creates a localization of FA in the cell.In Vivo Results
![](https://static.igem.org/mediawiki/2017/4/48/RNA_organelle.png)
![](https://static.igem.org/mediawiki/2017/f/fa/Log_phase_Aggregates.png)
![](https://static.igem.org/mediawiki/2017/e/e6/20h_RNA_Aggregates.png)
Fig 4 shows that as the expression of FA and FB are increased through arabinose induction, we see an increase in the overall GFP signal, which indicates the performance of the non-specific binding of the FA-FB. For the cultures that were also induced with the formation of the RNA organelle with the FA and FB components, we can see that there is a much lower background signal. This could be explained by the low affinity of FA and FB aggregation. When RNA organelle rapidly recruits all the FA, FB in the cytoplasm is unable to find its substrate. As predicted by our model, the RNA organelle removes non-specific reactions in synthetic systems. Fig. 5 and fig. 6 both a log phase and 20h time points respectively, showing that the aggregations are long-living as they can still be seen at the 20h point. Additionally, this is evidence that the system is irreversible. The data adds more evidence that the synthetic organelle could be used in a cell-free system.
Synthesis of CAG Repeats
![](https://static.igem.org/mediawiki/2017/d/db/RNA_wiki_2.png)
A collection of repeat sequences was built using two oligonucleotides: 10xCAG and 10xCTG. Through testing a variety of oligonucleotide concentrations and testing a different of PCR conditions, a specific protocol was built to synthesise various lenths of DNA containing CAG repeats. The resulting product appeared as a smear, indicating a range of lengths was created, the product was subsequently transformed into a T7 containing vector in order to produce RNA containing CAG repeats.